The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies

M. S. Van Der Veer; M. De Weers; B. Van Kessel; J. M. Bakker; S. Wittebol; P. W H I Parren; H. M. Lokhorst; T. Mutis

doi:https://doi.org/10.1038/bcj.2011.42

The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies

M. S. Van Der Veer, M. De Weers, B. Van Kessel, J. M. Bakker, S. Wittebol, P. W H I Parren, H. M. Lokhorst, T. Mutis

Research output: Contribution to journal › Letter › Academic › peer-review

84 Citations (Scopus)

Original language	English
Article number	e41
Journal	Blood Cancer Journal
Volume	1
Issue number	10
DOIs	https://doi.org/10.1038/bcj.2011.42
Publication status	Published - 1 Oct 2011

Access to Document

https://doi.org/10.1038/bcj.2011.42

Cite this

@article{97f19abeb0ff497da39cb9119f0e54a4,

title = "The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies",

author = "{Van Der Veer}, {M. S.} and {De Weers}, M. and {Van Kessel}, B. and Bakker, {J. M.} and S. Wittebol and Parren, {P. W H I} and Lokhorst, {H. M.} and T. Mutis",

year = "2011",

month = oct,

day = "1",

doi = "https://doi.org/10.1038/bcj.2011.42",

language = "English",

volume = "1",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "10",

}

TY - JOUR

T1 - The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies

AU - Van Der Veer, M. S.

AU - De Weers, M.

AU - Van Kessel, B.

AU - Bakker, J. M.

AU - Wittebol, S.

AU - Parren, P. W H I

AU - Lokhorst, H. M.

AU - Mutis, T.

PY - 2011/10/1

Y1 - 2011/10/1

UR - http://www.scopus.com/inward/record.url?scp=84864061825&partnerID=8YFLogxK

U2 - https://doi.org/10.1038/bcj.2011.42

DO - https://doi.org/10.1038/bcj.2011.42

M3 - Letter

C2 - 22829073

SN - 2044-5385

VL - 1

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 10

M1 - e41

ER -

The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies

Access to Document

Other files and links

Cite this